---
title: "Predictive Oncology Rebrands to Axe Compute Inc. on Nasdaq"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/269577140.md"
description: "Predictive Oncology has rebranded to Axe Compute Inc. and started trading on Nasdaq under the ticker AGPU. The company is expanding into high-performance AI infrastructure, leveraging the Aethir network for scalable GPU capacity. CEO Raymond F. Vennare's employment agreement was amended, increasing his salary and bonus eligibility. The stock is rated as Hold with a $5.00 price target, despite poor financial performance and bearish technical analysis. Axe Compute aims to address AI infrastructure bottlenecks in the AI-driven drug discovery industry."
datetime: "2025-12-12T22:53:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/269577140.md)
  - [en](https://longbridge.com/en/news/269577140.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/269577140.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/269577140.md) | [繁體中文](https://longbridge.com/zh-HK/news/269577140.md)


# Predictive Oncology Rebrands to Axe Compute Inc. on Nasdaq

### Claim 50% Off TipRanks Premium and Invest with Confidence

-   Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential

An announcement from Predictive Oncology ( (POAI) ) is now available.

On December 10, 2025, Axe Compute Inc. amended the employment agreement with CEO Raymond F. Vennare, increasing his salary and outlining bonus eligibility. On December 12, 2025, the company announced its name change to Axe Compute Inc. and began trading on Nasdaq under the ticker AGPU. The company plans to expand its operations into high-performance AI infrastructure, positioning itself as a key player in addressing the infrastructure bottleneck in AI development by utilizing the Aethir network to provide scalable GPU capacity.

The most recent analyst rating on (POAI) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on Predictive Oncology stock, see the POAI Stock Forecast page.

**Spark’s Take on POAI Stock**

According to Spark, TipRanks’ AI Analyst, POAI is a Neutral.

The overall stock score is primarily impacted by the company’s poor financial performance and valuation, which are offset slightly by positive corporate events such as regaining Nasdaq compliance and securing substantial private placements. The technical analysis indicates bearish momentum, further weighing down the score.

To see Spark’s full report on POAI stock, click here.

**More about Predictive Oncology**

Axe Compute Inc., formerly known as Predictive Oncology Inc., operates in the AI-driven drug discovery industry and is expanding into high-performance enterprise AI infrastructure. The company aims to address the growing demand for scalable compute capacity across AI workloads by leveraging its access to the Aethir network, which provides decentralized global infrastructure and GPU services.

**Average Trading Volume:** 105,515

**Technical Sentiment Signal:** Sell

**Current Market Cap:** $20.09M

### 相关股票

- [Axe Compute (AGPU.US)](https://longbridge.com/zh-CN/quote/AGPU.US.md)

## 相关资讯与研究

- [Insig AI Plans Growth Drive and Eyes Nasdaq Dual Listing](https://longbridge.com/zh-CN/news/281311983.md)
- [How to use AI to take over your workflow (without writing code)](https://longbridge.com/zh-CN/news/281679655.md)
- [The top AI semiconductor stocks to buy right now](https://longbridge.com/zh-CN/news/281647977.md)
- [Hamilton AI Selects Column as Its Banking Infrastructure Partner](https://longbridge.com/zh-CN/news/281413609.md)
- [Kyndryl launches Agentic Service Management to power AI-native infrastructure services and intelligent workflows | KD Stock News](https://longbridge.com/zh-CN/news/281461999.md)